PNTG
HealthcareThe Pennant Group, Inc. · Medical - Care Facilities · $1B
What is The Pennant Group, Inc.?
The Pennant Group is a US-based healthcare services company operating across home health, hospice, and senior living segments. Incorporated in 2019 and headquartered in Eagle, Idaho, it serves patients and seniors across more than a dozen states.
Pennant generates revenue by delivering care services through two main segments. Its Home Health and Hospice division provides nursing, therapy, and end-of-life counseling to patients in their homes. Its Senior Living segment operates residential communities offering meals, activities, housekeeping, and daily living assistance to independent and assisted-living residents across the western and central United States.
The Pennant Group was incorporated in 2019 and is headquartered in Eagle, Idaho.
- Home health nursing and therapy services
- Hospice and palliative care for terminally ill patients
- Senior living residential communities
- Medical social work and home health aide services
Is PNTG a Good Stock to Buy?
UQS Score rates PNTG as Below Average overall.
The standout element in Pennant's profile is its Growth pillar, which ranks among the stronger readings in the healthcare services space — reflecting the company's expanding footprint of agencies and senior living communities. This growth trajectory is a meaningful positive for investors focused on long-term scale.
However, the Quality, Moat, and Risk pillars all register as Weak, signaling concerns around earnings durability, competitive positioning, and balance sheet or operational vulnerabilities that investors should weigh carefully.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does PNTG pay dividends?
No — The Pennant Group, Inc. does not currently pay a dividend.
PNTG does not currently pay a dividend. For a growth-oriented healthcare services company at Pennant's stage, this is typical — available capital tends to be directed toward expanding agency count, entering new markets, and building operational infrastructure rather than returning cash to shareholders.
When does PNTG report earnings?
The Pennant Group reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
Pennant's Growth pillar suggests the company has been expanding its revenue base, though the Weak Quality and Risk readings indicate that translating top-line growth into consistent profitability remains a challenge. Investors should monitor how margins and cash generation trend as the network scales.
For the most recent quarter's results and guidance, visit The Pennant Group's investor relations page directly.
PNTG Price History
+55.7% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in The Pennant Group, Inc.?
Based on The Pennant Group, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
PNTG Long-term Outlook
Pennant's Strong Growth pillar points to a business that is actively expanding its care network, supported by favorable demographic tailwinds as the US population ages. That said, the Weak Risk pillar introduces meaningful uncertainty — operational leverage in healthcare services can amplify both gains and losses. The Neutral Valuation pillar suggests the market is neither deeply discounting nor richly pricing in the growth story at current levels.
Growth drivers
- Aging US population increasing demand for home health and hospice services
- Continued geographic expansion of agency and senior living footprint
- Shift toward lower-cost home-based care models in the broader healthcare system
Key risks
- Reimbursement rate changes from Medicare and Medicaid programs
- High operational complexity across a multi-state, multi-segment network
- Weak Quality and Moat scores suggesting limited pricing power and earnings consistency
PNTG vs Peers
Pennant operates in a fragmented healthcare services landscape alongside a range of home health, hospice, and outpatient care providers.
WELL Health focuses on digital and omnichannel primary care delivery, bringing a technology-forward approach that contrasts with Pennant's community-based, in-person care model.
InnovAge specializes in the PACE program for frail elderly patients, targeting a narrower and more medically complex population than Pennant's broader senior living and home health mix.
US Physical Therapy concentrates on outpatient physical and occupational therapy clinics, giving it a more specialized and clinic-based revenue model compared to Pennant's diversified care segments.
Frequently Asked Questions
What does The Pennant Group do?
The Pennant Group provides home health, hospice, and senior living services across more than a dozen US states. It delivers nursing, therapy, and end-of-life care to patients at home, and operates residential communities for seniors who need daily living support.
Does PNTG pay dividends?
No, PNTG does not currently pay a dividend. The company is in a growth phase, and available capital appears directed toward expanding its network of agencies and senior living communities rather than distributing cash to shareholders.
When does PNTG report earnings?
The Pennant Group follows a standard quarterly earnings cadence for US-listed companies. For exact dates and the most recent results, check The Pennant Group's investor relations page, as our data source does not cover specific upcoming earnings dates.
Is PNTG a good stock to buy?
UQS Score rates PNTG as Below Average overall. While the Growth pillar is Strong, the Quality, Moat, and Risk pillars are all Weak — meaning the growth story comes with meaningful execution and financial risk. Investors should review the full pillar breakdown before forming a view.
Is PNTG overvalued?
The UQS Valuation pillar for PNTG is rated Neutral, suggesting the stock is neither clearly cheap nor obviously expensive relative to its fundamentals. Whether that represents fair value depends on how investors weigh the Strong Growth profile against the Weak Quality and Risk scores.
How does PNTG compare to its competitors?
Pennant operates across home health, hospice, and senior living — a broader mix than some peers. Competitors like InnovAge focus on narrower patient populations, while WELL Health leans into digital care delivery. Each has a distinct model, and UQS pillar comparisons are available to Pro members.
What is PNTG's market cap bracket?
PNTG is classified as a small-cap stock. This means it carries the growth potential often associated with smaller healthcare operators, but also the higher volatility and liquidity risk typical of companies at this size.
Who founded The Pennant Group?
The Pennant Group was incorporated in 2019 as a spin-off from Ensign Group. Founding and leadership context is publicly available through the company's official filings and investor relations materials.
Is PNTG a long-term quality investment?
From a UQS quality-indicator perspective, PNTG's long-term profile is mixed. The Strong Growth pillar is encouraging for long-horizon investors, but Weak scores in Quality, Moat, and Risk suggest the business has not yet demonstrated the durability and competitive insulation typically associated with high-quality long-term holdings.
What is the main competitive advantage of The Pennant Group?
Pennant's primary edge lies in its decentralized operating model, which gives local leaders autonomy to serve their communities. However, the UQS Moat pillar rates this as Weak, indicating the structural competitive advantages are not yet strongly differentiated relative to the broader healthcare services sector.
Unlock Full PNTG Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar scores for PNTG
- ✓Access full financial metrics and trend data
- ✓Compare PNTG side-by-side with competitors on every pillar
- ✓See how PNTG ranks within the healthcare services sector
- ✓Get the complete analyst-style quality breakdown in one place
Pro Analysis
PNTG — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | 17.5 | 7.8 | 24.0 | 0.0 | 36.9 | 26.7 | -24.8 |
| Aug 1, 2026 | 42.3 | 26.3 | 24.0 | 90.8 | 33.7 | 43.6 | +0.1 |
| Jul 25, 2026 | 42.2 | 26.1 | 24.0 | 90.8 | 33.7 | 42.8 | -0.2 |
| Jul 24, 2026 | 42.4 | 26.3 | 24.0 | 90.8 | 33.7 | 44.0 | +0.1 |
| Jul 23, 2026 | 42.3 | 26.3 | 24.0 | 90.8 | 33.7 | 43.4 | +0.2 |
| Jul 22, 2026 | 42.1 | 26.1 | 24.0 | 90.8 | 33.7 | 42.6 | -0.1 |
| Jul 21, 2026 | 42.2 | 26.1 | 24.0 | 90.8 | 33.7 | 42.8 | +0.2 |
| Jul 18, 2026 | 42.0 | 26.0 | 24.0 | 90.8 | 33.7 | 42.1 | -0.1 |
| Jul 17, 2026 | 42.1 | 26.1 | 24.0 | 90.8 | 33.7 | 42.3 | -0.3 |
| Jul 16, 2026 | 42.4 | 26.3 | 24.0 | 90.8 | 33.7 | 43.8 | 0.0 |
PNTG — Pillar Breakdown
Quality
— 7.8/100 (25%)The Pennant Group, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Ability to convert revenue into operating profit.
Free cash flow relative to market value.
Growth
— 0.0/100 (20%)The Pennant Group, Inc. faces growth headwinds with declining or stagnant revenue trends.
Revenue trajectory over the last twelve months.
Analyst consensus for future revenue growth.
Risk
— 36.9/100 (15%)The Pennant Group, Inc. has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 26.7/100 (15%)The Pennant Group, Inc. appears expensively valued relative to its fundamentals and growth prospects.
How many years of FCF the market cap represents.
Moat
— 24/100 (25%)The Pennant Group, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for PNTG.
Score Composition
Financial Data
More Stock Analysis
How is the PNTG UQS Score Calculated?
The UQS (Unified Quality Score) for The Pennant Group, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses The Pennant Group, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether The Pennant Group, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.